ArticleNature communications2026
Complement inhibition by a unique cluster of immunomodulatory outer surface proteins of Borrelia recurrentis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Borrelia recurrentis, the agent of louse-borne relapsing fever, causes a poverty-associated, infectious disease of high mortality. Here, we identified and characterized five Complement targeting and Host Interacting proteins, ChiA to ChiE displaying immunomodulatory functions. Almost all Chi homologs inhibit complement activation by direct binding of key components, block membrane attack complex formation, and interact with plasminogen. Borrelia proteins protect susceptible spirochetes from complement-mediated killing and ChiB, ChiC, and ChiD facilitate serum resistance. X-ray structures of ChiA and ChiB, along with AlphaFold models of ChiC, ChiD, and ChiE, reveal a conserved, compact eight-helix fold with a central hydrophobic pocket and a unique S-domain-feature distinct from all known Borrelia proteins. Notably, ChiC and ChiE harbor conserved cysteines forming a reversible disulfide bridge, indicating redox-responsive function. Our findings identify a protein family of functionally related immune evasion factors, advancing our understanding of the underlying mechanisms of complement resistance in this neglected, human pathogenic microorganism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.